CYTK
Cytokinetics, Incorporated (CYTK) Sec Form 10K
Cytokinetics, Incorporated (NASDAQ: CYTK) Sec Form 10K
Cytokinetics, Incorporated (CYTK) Sec Form 8K
Cytokinetics, Incorporated (NASDAQ: CYTK) Sec Form 8K
Cytokinetics, Incorporated (CYTK) Q4 2025 Earnings Call
Cytokinetics, Incorporated (NASDAQ: CYTK) Q4 2025 Earnings Release
Cytokinetics, Incorporated (CYTK) Sec Form 8K
Cytokinetics, Incorporated (NASDAQ: CYTK) Sec Form 8K
Cytokinetics, Incorporated (CYTK) Cytokinetics Announces European Commission Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
Cytokinetics, Incorporated (NASDAQ: CYTK) FY 2026 Other Release
Cytokinetics, Incorporated (CYTK) Q4 2025 Earnings Call
Cytokinetics, Incorporated (NASDAQ: CYTK) Q4 2025 Earnings Conference
Cytokinetics, Incorporated (CYTK) Q4 2025 Earnings Announcement
Cytokinetics, Incorporated (NASDAQ: CYTK) Q4 2025 Earnings Announcement
Cytokinetics, Incorporated (CYTK) Cytokinetics Announces Recipients of Its Eighth Annual Communications Grant Program
Cytokinetics, Incorporated (NASDAQ: CYTK) FY 2026 Other Release